モノクローナル抗体の世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Monoclonal Antibodies Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-10728 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、モノクローナル抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。モノクローナル抗体の種類別市場規模（がん、自己免疫疾患、感染症、血液疾患、その他）、用途別市場規模（腫瘍学、自己免疫疾患、炎症性疾患、呼吸器疾患、眼科）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Formation Biologics、Amgen、Roche、Eli Lilly、Johnson & Johnson、GlaxoSmithKline、BMS、Merck、Genmab、Pfizer、Synthon Biopharmaceuticals、Human Genome Sciences、Teva、Seattle Genetics、Novartis、mmunogen、Takeda、Stemcentrx、MedImmune ・地域別グローバル市場分析 2015年-2020年 ・モノクローナル抗体の北米市場（アメリカ、カナダ、メキシコ） ・モノクローナル抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・モノクローナル抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・モノクローナル抗体の南米市場（ブラジル、アルゼンチン） ・モノクローナル抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：がん、自己免疫疾患、感染症、血液疾患、その他 ・用途別分析：腫瘍学、自己免疫疾患、炎症性疾患、呼吸器疾患、眼科 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Monoclonal Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Monoclonal Antibodies market has been segmented into
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others

By Application, Monoclonal Antibodies has been segmented into:
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Monoclonal Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level Monoclonal Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Monoclonal Antibodies market.

The report offers in-depth assessment of the growth and other aspects of the Monoclonal Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Monoclonal Antibodies Market Share Analysis
Monoclonal Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Monoclonal Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Monoclonal Antibodies sales, revenue and market share for each player covered in this report.

The major players covered in Monoclonal Antibodies are:
AbbVie
Formation Biologics
Amgen
Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
BMS
Merck
Genmab
Pfizer
Synthon Biopharmaceuticals
Human Genome Sciences
Teva
Seattle Genetics
Novartis
mmunogen
Takeda
Stemcentrx
MedImmune

Among other players domestic and global, Monoclonal Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Monoclonal Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Monoclonal Antibodies, with price, sales, revenue and global market share of Monoclonal Antibodies in 2018 and 2019.
Chapter 3, the Monoclonal Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monoclonal Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Monoclonal Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Infection
1.2.5 Hematological Diseases
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Autoimmune and inflammatory diseases
1.3.4 Respiratory diseases
1.3.5 Ophthalmology
1.4 Overview of Global Monoclonal Antibodies Market
1.4.1 Global Monoclonal Antibodies Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Formation Biologics
2.2.1 Formation Biologics Details
2.2.2 Formation Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Formation Biologics SWOT Analysis
2.2.4 Formation Biologics Product and Services
2.2.5 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline SWOT Analysis
2.7.4 GlaxoSmithKline Product and Services
2.7.5 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BMS
2.8.1 BMS Details
2.8.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BMS SWOT Analysis
2.8.4 BMS Product and Services
2.8.5 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck SWOT Analysis
2.9.4 Merck Product and Services
2.9.5 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genmab
2.10.1 Genmab Details
2.10.2 Genmab Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genmab SWOT Analysis
2.10.4 Genmab Product and Services
2.10.5 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer SWOT Analysis
2.11.4 Pfizer Product and Services
2.11.5 Pfizer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Synthon Biopharmaceuticals
2.12.1 Synthon Biopharmaceuticals Details
2.12.2 Synthon Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Synthon Biopharmaceuticals SWOT Analysis
2.12.4 Synthon Biopharmaceuticals Product and Services
2.12.5 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Human Genome Sciences
2.13.1 Human Genome Sciences Details
2.13.2 Human Genome Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Human Genome Sciences SWOT Analysis
2.13.4 Human Genome Sciences Product and Services
2.13.5 Human Genome Sciences Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Teva SWOT Analysis
2.14.4 Teva Product and Services
2.14.5 Teva Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Seattle Genetics
2.15.1 Seattle Genetics Details
2.15.2 Seattle Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Seattle Genetics SWOT Analysis
2.15.4 Seattle Genetics Product and Services
2.15.5 Seattle Genetics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Novartis SWOT Analysis
2.16.4 Novartis Product and Services
2.16.5 Novartis Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 mmunogen
2.17.1 mmunogen Details
2.17.2 mmunogen Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 mmunogen SWOT Analysis
2.17.4 mmunogen Product and Services
2.17.5 mmunogen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Takeda SWOT Analysis
2.18.4 Takeda Product and Services
2.18.5 Takeda Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Stemcentrx
2.19.1 Stemcentrx Details
2.19.2 Stemcentrx Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Stemcentrx SWOT Analysis
2.19.4 Stemcentrx Product and Services
2.19.5 Stemcentrx Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 MedImmune
2.20.1 MedImmune Details
2.20.2 MedImmune Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 MedImmune SWOT Analysis
2.20.4 MedImmune Product and Services
2.20.5 MedImmune Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Monoclonal Antibodies Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Monoclonal Antibodies Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2019
3.3.2 Top 6 Monoclonal Antibodies Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Monoclonal Antibodies Sales and Market Share by Regions (2015-2020)
4.1.2 Global Monoclonal Antibodies Revenue and Market Share by Regions (2015-2020)
4.2 North America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.3 Europe Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.5 South America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Monoclonal Antibodies Sales, Revenue and Market Share by Country
5.1.1 North America Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
5.1.2 North America Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
5.2 United States Monoclonal Antibodies Sales and Growth Rate (2015-2020)
5.3 Canada Monoclonal Antibodies Sales and Growth Rate (2015-2020)
5.4 Mexico Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Country
6.1.1 Europe Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
6.1.2 Europe Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
6.2 Germany Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.3 UK Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.4 France Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.5 Russia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.6 Italy Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Monoclonal Antibodies Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Monoclonal Antibodies Revenue and Market Share by Regions (2015-2020)
7.2 China Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.3 Japan Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.4 Korea Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.5 India Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.7 Australia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Monoclonal Antibodies Sales, Revenue and Market Share by Country
8.1.1 South America Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
8.1.2 South America Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
8.2 Brazil Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.3 Argentina Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Monoclonal Antibodies Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Monoclonal Antibodies Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Monoclonal Antibodies Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.3 Turkey Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.4 Egypt Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.5 South Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Monoclonal Antibodies Sales and Market Share by Type (2015-2020)
10.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
10.3 Global Monoclonal Antibodies Price by Type (2015-2020)
11 Global Monoclonal Antibodies Market Segment by Application
11.1 Global Monoclonal Antibodies Sales Market Share by Application (2015-2020)
11.2 Global Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
11.3 Global Monoclonal Antibodies Price by Application (2015-2020)
12 Market Forecast
12.1 Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2021-2025)
12.2 Monoclonal Antibodies Market Forecast by Regions (2021-2025)
12.2.1 North America Monoclonal Antibodies Market Forecast (2021-2025)
12.2.2 Europe Monoclonal Antibodies Market Forecast (2021-2025)
12.2.3 Asia-Pacific Monoclonal Antibodies Market Forecast (2021-2025)
12.2.4 South America Monoclonal Antibodies Market Forecast (2021-2025)
12.2.5 Middle East & Africa Monoclonal Antibodies Market Forecast (2021-2025)
12.3 Monoclonal Antibodies Market Forecast by Type (2021-2025)
12.3.1 Global Monoclonal Antibodies Sales Forecast by Type (2021-2025)
12.3.2 Global Monoclonal Antibodies Market Share Forecast by Type (2021-2025)
12.4 Monoclonal Antibodies Market Forecast by Application (2021-2025)
12.4.1 Global Monoclonal Antibodies Sales Forecast by Application (2021-2025)
12.4.2 Global Monoclonal Antibodies Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Monoclonal Antibodies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Monoclonal Antibodies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Monoclonal Antibodies Major Business
Table 9. AbbVie Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Monoclonal Antibodies Product and Services
Table 12. AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Formation Biologics Basic Information, Manufacturing Base and Competitors
Table 14. Formation Biologics Monoclonal Antibodies Major Business
Table 15. Formation Biologics Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 16. Formation Biologics SWOT Analysis
Table 17. Formation Biologics Monoclonal Antibodies Product and Services
Table 18. Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Monoclonal Antibodies Major Business
Table 21. Amgen Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 22. Amgen SWOT Analysis
Table 23. Amgen Monoclonal Antibodies Product and Services
Table 24. Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Roche Basic Information, Manufacturing Base and Competitors
Table 26. Roche Monoclonal Antibodies Major Business
Table 27. Roche Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 28. Roche SWOT Analysis
Table 29. Roche Monoclonal Antibodies Product and Services
Table 30. Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Monoclonal Antibodies Major Business
Table 33. Eli Lilly Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 34. Eli Lilly SWOT Analysis
Table 35. Eli Lilly Monoclonal Antibodies Product and Services
Table 36. Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Monoclonal Antibodies Major Business
Table 39. Johnson & Johnson Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Monoclonal Antibodies Product and Services
Table 42. Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Monoclonal Antibodies Major Business
Table 45. GlaxoSmithKline Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 46. GlaxoSmithKline SWOT Analysis
Table 47. GlaxoSmithKline Monoclonal Antibodies Product and Services
Table 48. GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. BMS Basic Information, Manufacturing Base and Competitors
Table 50. BMS Monoclonal Antibodies Major Business
Table 51. BMS Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 52. BMS SWOT Analysis
Table 53. BMS Monoclonal Antibodies Product and Services
Table 54. BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Merck Basic Information, Manufacturing Base and Competitors
Table 56. Merck Monoclonal Antibodies Major Business
Table 57. Merck Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 58. Merck SWOT Analysis
Table 59. Merck Monoclonal Antibodies Product and Services
Table 60. Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Genmab Basic Information, Manufacturing Base and Competitors
Table 62. Genmab Monoclonal Antibodies Major Business
Table 63. Genmab Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 64. Genmab SWOT Analysis
Table 65. Genmab Monoclonal Antibodies Product and Services
Table 66. Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Monoclonal Antibodies Major Business
Table 69. Pfizer Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 70. Pfizer SWOT Analysis
Table 71. Pfizer Monoclonal Antibodies Product and Services
Table 72. Pfizer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Synthon Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Synthon Biopharmaceuticals Monoclonal Antibodies Major Business
Table 75. Synthon Biopharmaceuticals Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 76. Synthon Biopharmaceuticals SWOT Analysis
Table 77. Synthon Biopharmaceuticals Monoclonal Antibodies Product and Services
Table 78. Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Human Genome Sciences Basic Information, Manufacturing Base and Competitors
Table 80. Human Genome Sciences Monoclonal Antibodies Major Business
Table 81. Human Genome Sciences Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 82. Human Genome Sciences SWOT Analysis
Table 83. Human Genome Sciences Monoclonal Antibodies Product and Services
Table 84. Human Genome Sciences Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Teva Basic Information, Manufacturing Base and Competitors
Table 86. Teva Monoclonal Antibodies Major Business
Table 87. Teva Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 88. Teva SWOT Analysis
Table 89. Teva Monoclonal Antibodies Product and Services
Table 90. Teva Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 92. Seattle Genetics Monoclonal Antibodies Major Business
Table 93. Seattle Genetics Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 94. Seattle Genetics SWOT Analysis
Table 95. Seattle Genetics Monoclonal Antibodies Product and Services
Table 96. Seattle Genetics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Novartis Basic Information, Manufacturing Base and Competitors
Table 98. Novartis Monoclonal Antibodies Major Business
Table 99. Novartis Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 100. Novartis SWOT Analysis
Table 101. Novartis Monoclonal Antibodies Product and Services
Table 102. Novartis Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. mmunogen Basic Information, Manufacturing Base and Competitors
Table 104. mmunogen Monoclonal Antibodies Major Business
Table 105. mmunogen Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 106. mmunogen SWOT Analysis
Table 107. mmunogen Monoclonal Antibodies Product and Services
Table 108. mmunogen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Takeda Monoclonal Antibodies Type and Application
Table 110. Takeda Monoclonal Antibodies Major Business
Table 111. Takeda Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 112. Takeda SWOT Analysis
Table 113. Takeda Monoclonal Antibodies Product and Services
Table 114. Takeda Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Stemcentrx Basic Information, Manufacturing Base and Competitors
Table 116. Stemcentrx Monoclonal Antibodies Major Business
Table 117. Stemcentrx Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 118. Stemcentrx SWOT Analysis
Table 119. Stemcentrx Monoclonal Antibodies Product and Services
Table 120. Stemcentrx Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. MedImmune Basic Information, Manufacturing Base and Competitors
Table 122. MedImmune Monoclonal Antibodies Major Business
Table 123. MedImmune Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 124. MedImmune SWOT Analysis
Table 125. MedImmune Monoclonal Antibodies Product and Services
Table 126. MedImmune Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Monoclonal Antibodies Sales by Manufacturer (2018-2019) (Kg)
Table 128. Global Monoclonal Antibodies Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Monoclonal Antibodies Sales by Regions (2015-2020) (Kg)
Table 130. Global Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table 131. Global Monoclonal Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Monoclonal Antibodies Sales by Countries (2015-2020) (Kg)
Table 133. North America Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 134. North America Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 136. Europe Monoclonal Antibodies Sales by Countries (2015-2020) (Kg)
Table 137. Europe Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 138. Europe Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Monoclonal Antibodies Sales by Regions (2015-2020) (Kg)
Table 140. Asia-Pacific Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Monoclonal Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Monoclonal Antibodies Sales by Countries (2015-2020) (Kg)
Table 143. South America Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 144. South America Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Monoclonal Antibodies Sales by Countries (2015-2020) (Kg)
Table 147. Middle East & Africa Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Monoclonal Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 150. Global Monoclonal Antibodies Sales by Type (2015-2020) (Kg)
Table 151. Global Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 152. Global Monoclonal Antibodies Revenue by Type (2015-2020) (USD Million)
Table 153. Global Monoclonal Antibodies Revenue Share by Type (2015-2020)
Table 154. Global Monoclonal Antibodies Sales by Application (2015-2020) (Kg)
Table 155. Global Monoclonal Antibodies Sales Share by Application (2015-2020)
Table 156. Global Monoclonal Antibodies Sales Forecast by Regions (2021-2025) (Kg)
Table 157. Global Monoclonal Antibodies Market Share Forecast by Regions (2021-2025)
Table 158. Global Monoclonal Antibodies Sales Forecast by Type (2021-2025) (Kg)
Table 159. Global Monoclonal Antibodies Market Share Forecast by Type (2021-2025)
Table 160. Global Monoclonal Antibodies Sales Forecast by Application (2021-2025)
Table 161. Global Monoclonal Antibodies Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Monoclonal Antibodies Picture
Figure 2. Global Sales Market Share of Monoclonal Antibodies by Type in 2019
Figure 3. Cancer Picture
Figure 4. Autoimmune Diseases Picture
Figure 5. Infection Picture
Figure 6. Hematological Diseases Picture
Figure 7. Others Picture
Figure 8. Monoclonal Antibodies Sales Market Share by Application in 2018
Figure 9. Oncology Picture
Figure 10. Autoimmune and inflammatory diseases Picture
Figure 11. Respiratory diseases Picture
Figure 12. Ophthalmology Picture
Figure 13. Global Monoclonal Antibodies Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Monoclonal Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2019
Figure 34. Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 39. Global Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Monoclonal Antibodies Revenue Market Share by Regions (2015-2020)
Figure 41. Global Monoclonal Antibodies Revenue Market Share by Regions in 2018
Figure 42. North America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 43. Europe Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 45. South America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure 47. North America Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Figure 49. North America Monoclonal Antibodies Sales Market Share by Countries in 2018
Figure 50. North America Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Monoclonal Antibodies Revenue Market Share by Countries in 2018
Figure 52. United States Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 53. Canada Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 54. Mexico Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 55. Europe Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 58. Germany Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 59. UK Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 60. France Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 61. Russia Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 62. Italy Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 63. Asia-Pacific Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Monoclonal Antibodies Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Monoclonal Antibodies Revenue Market Share by Regions 2019
Figure 66. China Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 67. Japan Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 68. Korea Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 69. India Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 70. Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 71. South America Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Monoclonal Antibodies Sales Market Share by Countries in 2019
Figure 73. South America Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 74. Brazil Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 75. Argentina Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 76. Middle East and Africa Monoclonal Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Monoclonal Antibodies Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 81. Egypt Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 82. Turkey Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 83. South Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020) (Kg)
Figure 84. Global Monoclonal Antibodies Sales and Growth Rate (2021-2025) (Kg)
Figure 85. Global Monoclonal Antibodies Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Monoclonal Antibodies Market Forecast (2021-2025) (Kg)
Figure 87. Europe Sales Monoclonal Antibodies Market Forecast (2021-2025) (Kg)
Figure 88. Asia-Pacific Sales Monoclonal Antibodies Market Forecast (2021-2025) (Kg)
Figure 89. South America Sales Monoclonal Antibodies Market Forecast (2021-2025) (Kg)
Figure 90. Middle East & Africa Sales Monoclonal Antibodies Market Forecast (2021-2025) (Kg)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel

---